Effect of β,β-dimethylacrylshikonin on inhibition of human colorectal cancer cell growth in vitro and in vivo

International Journal of Molecular Sciences

Volumn 13, Issue 7, 2012, Pages 9184-9193

  Fan, Yingying ^a   Jin, Shaoju ^b   He, Jun ^c   Shao, Zhenjun ^a   Yan, Jiao ^d   Feng, Ting ^a   Li, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

^d Chengdu Military General Hospital   (China)

Author keywords

Anti tumor; Apoptosis; Colorectal cancer; , dimethylacrylshikonin

Indexed keywords

BETA,BETA DIMETHYLACRYLSHIKONIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; SHIKONIN DERIVATIVE; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; BETA, BETA-DIMETHYLACRYLSHIKONIN; BID PROTEIN, HUMAN; NAPHTHOQUINONE; PROTEIN BCL X;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G2 PHASE; CELL VIABILITY; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MICE; MICE, NUDE; NAPHTHOQUINONES; PROTO-ONCOGENE PROTEINS C-BCL-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84864354649     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13079184     Document Type: Article

References (20)

1. Scripture, C.D.; Figg, W.D. Drug interactions in cancer therapy. Nat. Rev. Cancer 2006, 6, 546-558.
2. Wang, C.C.; Li, J. An update on chemotherapy of colorectal liver metastases. World J. Gastroenterol. 2012, 18, 25-33.
3. Nagoor, N.H.; Muttiah, N.S.J.; Lim, C.S.; In, L.L.; Mohamad, K.; Awang, K. Regulation of apoptotic effects by erythrocarpine E, a cytotoxic limonoid from Chisocheton erythrocarpus in HSC-4 human oral cancer cells. PLoS One 2011, 6, e23661.
4. Assimopoulou, A.N.; Sturm, S.; Stuppner, H.; Papageorgiou, V.P. Preparative isolation and purification of alkannin/shikonin derivatives from natural products by high-speed counter-current chromatography. Biomed. Chromatogr. 2009, 23, 182-198.
5. Zeng, Y.; Liu, G.; Zhou, L.M. Inhibitory effects of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo. World J. Gastroenterol. 2009, 15, 1816-1820.
6. Wu, Y.Y.; Wan, L.H.; Zheng, X.W.; Shao, Z.J.; Chen, J.; Liu, L.T.; Kuang, W.J.; Tan, X.S.; Zhou, L.M. Inhibitory effects of β,β-dimethylacrylshikonin on hepatocellular carcinoma in vitro and in vivo. Phytother. Res. 2012, 26, 764-771.
7. Staniforth, V.; Wang, S.Y.; Shyur, L.F.; Yang, N.S. Shikonins, phytocompounds from Lithospermum erythrorhizon, inhibit the transcriptional activation of human tumor necrosis factor alpha promoter in vivo. J. Biol. Chem. 2004, 279, 5877-5885.
8. Wang, Z.; Liu, T.; Gan, L.; Wang, T.; Yuan, X.; Zhang, B.; Chen, H.; Zheng, Q. Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity. Eur. J. Pharmacol. 2010, 643, 211-217.
9. Ko, F.N.; Lee, Y.S.; Kuo, S.C.; Chang, Y.S.; Teng, C.M. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. BBA-Mol. Cell Res. 1995, 1268, 329-334.
10. An, S.; Park, Y.D.; Paik, Y.K.; Jeong, T.S.; Lee, Y.S. Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorhizon. Bioorg. Medicinal Chem. Lett. 2007, 17, 1112-1116.
11. Han, W.; Xie, J.; Li, L.; Liu, Z.; Hu, X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 2009, 14, 674-686.
12. Hou, Y.; Guo, T.; Wu, C.; He, X.; Zhao, M. Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro. Yakugaku Zasshi 2006, 126, 1383-1386.
13. Min, R.; Tong, J.; Wenjun, Y.; Wenhu, D.; Xiaojian, Z.; Jiacai, H.; Jian, Z.; Wantao, C.; Chenping, Z. Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by shikonin was partly through the inactivation of NF-kappa B pathway. Phytother. Res. 2008, 22, 407-415.
14. Xiong, W.; Luo, G.; Zhou, L.; Zeng, Y.; Yang, W. In vitro and in vivo antitumor effects of acetylshikonin isolated from Arnebia euchroma (Royle) Johnst (Ruanzicao) cell suspension cultures. Chin. Med. 2009, 4, 14.
15. Kim, S.H.; Kang, I.C.; Yoon, T.J.; Park, Y.M.; Kang, K.S.; Song, G.Y.; Ahn, B.Z. Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33. Cancer Lett. 2001, 172, 171-175.
16. Lee, H.J.; Lee, H.J.; Magesh, V.; Nam, D.; Lee, E.O.; Ahn, K.S.; Jung, M.H.; Ahn, K.S.; Kim, D.K.; Kim, J.Y.; Kim, S.H. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice. Yakugaku Zasshi 2008, 128, 1681-1688.
17. Yano, H.; Mizoguchi, A.; Fukuda, K.; Haramaki, M.; Ogasawara, S.; Momosaki, S.; Kojiro, M. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 1994, 54, 448-454.
18. Reed, J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol. 1995, 7, 541-546.
19. McCurrach, M.E.; Connor, T.M.; Knudson, C.M.; Korsmeyer, S.J.; Lowe, S.W. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Nat. Acad. Sci. USA 1997, 94, 2345-2349.
20. Yin, C.; Knudson, C.M.; Korsmeyer, S.J.; Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997, 385, 637-640.